Prof Wu speaks with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting about the changing aetiology and incidence of lung cancer in China. He describes the developments in surgery and chemotherapy in treating lung cancer patients, and outlines how immunotherapy in adjuvant or neo-adjuvant...

Prof Toh speaks with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting about changing attitudes and understanding of immunotherapy. He considers the future development of T cell therapy, and using aspirin for chemoprevention of colorectal cancer progression. Prof Toh also describes the...